Clough Capital Partners L P Legend Biotech Corp Transaction History

Clough Capital Partners L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$46.28 - $75.01 $7.41 Million - $12 Million	-160,136 Reduced 79.58%	41,100 $2.84 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $7.07 Million - $9.34 Million	162,760 Added 423.02%	201,236 $9.7 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $4.65 Million - $6.64 Million	-119,749 Reduced 75.68%	38,476 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $358,610 - $536,740	9,400 Added 6.32%	158,225 $6.46 Million
Q2 2022 Aug 16, 2022	BUY	$33.54 - $55.0 $641,754 - $1.05 Million	19,134 Added 14.75%	148,825 $8.19 Million
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $2.03 Million - $3.15 Million	-65,361 Reduced 33.51%	129,691 $4.71 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $8.02 Million - $11.1 Million	195,052 New	195,052 $9.09 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.